Clinical Trials Commenced for Immunogene Therapy: Advancing Small Cell Lung Cancer Treatment : Genprex; NASDAQ: GNPX
GNPX in combination with Genentech's Tecentriq® to treat patients with extensive-stage small cell lung cancer. Genentech became a member of the Roche Group Genprex, Inc. (NASDAQ:GNPX) AUSTIN, TEXAS, UNITED STATES , May 14, 2024 /EINPresswire.com …